Medical Technology in Singapore

Singapore offers an established advanced manufacturing ecosystem alongside stable operating environment, global connectivity, world-class infrastructure and skilled talent. 

These qualities support MedTech advanced manufacturing activities that are driven by Industry 4.0 which includes technologies such as Robotics, Artificial Intelligence, and Additive Manufacturing. 

Companies like Agilent and Medtronic have already established best-in-class facilities here.

Agilent’s Singapore site is one of seven World Economic Forum (WEF) lighthouse factories here. They harness Industry 4.0 technologies to achieve 60 per cent productivity gains and 80 per cent output growth.

Companies co-locate product development centres with manufacturing and commercial headquarters here, optimising technological transfer and operational efficiency. 

Globally leading MedTech companies including Biotronik and Illumina have substantial R&D footprints in Singapore. 

Biotronik has its Asia Pacific Manufacturing and Research hub for its state-of-the-art cardiac rhythm management devices here.

Singapore is home to Illumina’s first R&D centre in Asia, which houses a multinational team of hardware and software engineers who design and develop some of Illumina’s newest products. Illumina’s MiSeq sequencers are conceptualised, designed and manufactured out of Singapore.

Collaborations in Singapore go beyond the industry, and extend into the vibrant research and innovation ecosystems here.

MedTech giants like EssilorLuxottica work closely with the research community in Singapore to drive innovation. EssilorLuxottica has a team of around 50 scientists and engineers working on myopia research and product development here, partnering closely with the Singapore National Eye Centre and Singapore Eye Research Institute..

Supporting MedTech companies' R&D endeavours also include national initiatives like the S$38 million MedTech Catapult which helps accelerate MedTech innovation by supporting the translation of IP into commercial products. Our TRUST national platform also enables secure, anonymised health-related research collaboration.